Meeting
2023 ASCO Annual Meeting
Prognostic value of tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer (BC): A focus on inflammatory BC.
Authors
Eleonora Nicolò
Weill Cornell Medicine, New York, NY
Eleonora Nicolò , Laura Sofia Munoz-Arcos , Paolo D'Amico , Youbin Zhang , Lorenzo Gerratana , Marwa Manai , Mara Serena Serafini , Amanda Kaylan Strickland , Andrew A. Davis , Jeannine Donahue , Huiping Liu , William John Gradishar , Ami N. Shah , Giuseppe Curigliano , Carolina Reduzzi , Massimo Cristofanilli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1098)
DOI
10.1200/JCO.2023.41.16_suppl.1098
Abstract #
1098
Poster Bd #
319
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Clinical significance of circulating tumor cells (CTCs) in hormone receptor-positive (HR+) metastatic breast cancer (MBC) patients (pts) receiving letrozole (Let) or Let plus bevacizumab (Bev): CALGB 40503 (Alliance).
First Author: Mark Jesus Mendoza Magbanua
Poster
2018 ASCO Annual Meeting
The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “indolent” stage IV disease (Stage IVindolent).
First Author: Andrew A. Davis
Poster
2018 Genitourinary Cancers Symposium
Validation of a novel preoperative inflammatory score in localized, clear cell RCC.
First Author: Kevin Richard Melnick
Poster
2016 ASCO Annual Meeting
Correlation of circulating tumor cells (CTCs) with peripheral blood leukocytes to predict outcome in metastatic breast cancer (MBC).
First Author: Ugo De Giorgi